uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Jivadco
Application withdrawn
Human
Details
EMA number
EMEA/H/C/005654
ATC code
-
Authorisation
-
Revision
-
EMA page
Therapeutic indication
treatment of HER2 (Human Epidermal Growth Factor Receptor 2)-positive metastatic breast cancer
Group:
Antineoplastic agents
Active substances
trastuzumab duocarmazine
Marketing Authorisation Holder
medac Gesellschaft für klinische Spezialpräparate mbH
MAH
Jivadco | uMedical